Literature DB >> 29846889

Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.

Daniel J Ellenberger1,2, Dave A Miller3, Robert O Williams4.   

Abstract

Due to the high number of poorly soluble drugs in the development pipeline, novel processes for delivery of these challenging molecules are increasingly in demand. One such emerging method is KinetiSol, which utilizes high shear to produce amorphous solid dispersions. The process has been shown to be amenable to difficult to process active pharmaceutical ingredients with high melting points, poor organic solubility, or sensitivity to heat degradation. Additionally, the process enables classes of polymers not conventionally processable due to their high molecular weight and/or poor organic solubility. Beyond these advantages, the KinetiSol process shows promise with other applications, such as the production of amorphous mucoadhesive dispersions for delivery of compounds that would also benefit from permeability enhancement.

Entities:  

Keywords:  KinetiSol; amorphous solid dispersion (ASD); bioavailability; hot melt extrusion (HME); spray drying

Mesh:

Substances:

Year:  2018        PMID: 29846889     DOI: 10.1208/s12249-018-1007-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  7 in total

1.  Assessing the Interrelationship of Microstructure, Properties, Drug Release Performance, and Preparation Process for Amorphous Solid Dispersions Via Noninvasive Imaging Analytics and Material Characterization.

Authors:  Wei Jia; Phillip D Yawman; Keyur M Pandya; Kellie Sluga; Tania Ng; Dawen Kou; Karthik Nagapudi; Paul E Luner; Aiden Zhu; Shawn Zhang; Hao Helen Hou
Journal:  Pharm Res       Date:  2022-06-03       Impact factor: 4.200

Review 2.  Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.

Authors:  Amritha G Nambiar; Maan Singh; Abhishek R Mali; Dolores R Serrano; Rajnish Kumar; Anne Marie Healy; Ashish Kumar Agrawal; Dinesh Kumar
Journal:  AAPS PharmSciTech       Date:  2022-09-02       Impact factor: 4.026

3.  Systematic Development of Solid Lipid Nanoparticles of Abiraterone Acetate with Improved Oral Bioavailability and Anticancer Activity for Prostate Carcinoma Treatment.

Authors:  Sarwar Beg; Ankit K Malik; Mohammad Javed Ansari; Asrar A Malik; Ahmed Mahmoud Abdelhaleem Ali; Abdulrahman Theyab; Mohammad Algahtani; Waleed H Almalki; Khalid S Alharbi; Sattam K Alenezi; Md Abul Barkat; Mahfoozur Rahman; Hani Choudhry
Journal:  ACS Omega       Date:  2022-05-10

4.  Manufacturing strategies to develop amorphous solid dispersions: An overview.

Authors:  Nicole Mendonsa; Bjad Almutairy; Venkata Raman Kallakunta; Sandeep Sarabu; Priyanka Thipsay; Suresh Bandari; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-12-11       Impact factor: 3.981

Review 5.  Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs.

Authors:  Serena Bertoni; Beatrice Albertini; Nadia Passerini
Journal:  Molecules       Date:  2019-09-25       Impact factor: 4.411

6.  Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.

Authors:  Deck Khong Tan; Daniel A Davis; Dave A Miller; Robert O Williams; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2020-11-08       Impact factor: 3.246

7.  Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions.

Authors:  Urvi Gala; Dave Miller; Robert O Williams
Journal:  Pharmaceutics       Date:  2020-04-14       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.